Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dustar1986
    Junior Member
    • Sep 2011
    • 8

    #1

    Highly Inflated DE Result using Several Linear Models

    Dear Colleagues,

    I'm working on a disease treatment study. I got RNA-seq samples of cell-line from 7 patients and 7 normal persons (both consist of 3 males and 4 females). Each individual was given with 3 different treatments including a vehicle control. So that I got 42 RNA libraries in all.

    I tried several linear models. In DESeq2 and Limma I used a design to compare between and within groups, which looks like:
    Expression ~ Genotype + Genotype:Individual.nested + Genotype:Treatment

    As I got 42 samples, I think I'm kind of having enough observations to estimate variance in a normal way, instead of using the assumption that genes with similar expression levels would have similar dispersions. So I also tried a mixed model using lme4 package, and using batches and indivduals as random effects. It was built by LMM instead of GLMM:
    Expression ~ Genotype*Gender*Treatment + (1|Batch) + (1|Individual)

    When I calculated contrasts (i.e. Treatment A effect on Normal), all these models gave highly inflated raw p values (more than 8000 significant genes). Limma and DESeq2 results had a >95% overlap and they had a > 65% overlap with lme4. This doesn't make sense for me not just because of the p value distribution. Treatment A is a proved treatment on patient. This contrast, which test for its off-target on normal people, turned out a shocked result.

    I'm pretty sure the contrast was done in a correct way, involving the correct beta's. Any suggestion is really appreciated. Thanks a lot.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...